外用薬の開発・製造受託機関（CDMO）の世界市場レポート 2025年

外用薬の開発・製造受託機関（CDMO）市場規模は、今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）16.4％で1,130億6,000万米ドルに成長します。予測期間の成長は、個別化医療、生物製剤の拡大、R&D投資の増加、皮膚疾患有病率の上昇、先端製造技術に起因すると考えられます。予測期間における主な動向としては、革新的な製剤に対する需要の増加、ドラッグデリバリー技術の進歩、皮膚科学研究への投資の増加、製薬企業によるアウトソーシングの急増、個別化医療への注力、専門的な知識を必要とする厳しい規制要件、一般用医薬品（OTC）スキンケア製品に対する消費者の嗜好の高まりなどが挙げられます。

皮膚疾患の有病率の増加は、今後の外用薬の開発・製造受託機関（CDMO）市場の成長を牽引すると予想されます。皮膚疾患は、皮膚に影響を及ぼす病状であり、炎症、かゆみ、病変などの症状を引き起こします。皮膚疾患の有病率の上昇は、環境汚染、紫外線照射、遺伝的素因、ライフスタイルの変化、微生物感染などの要因に起因しています。外用薬CDMOは、皮膚疾患の管理・治療を改善する標的治療薬を開発・製造することで、皮膚疾患の蔓延を抑える手助けをしています。例えば、2024年1月、オーストラリアを拠点とするがん対策機関Cancer Australiaは、2019年から2023年にかけて皮膚黒色腫の症例数が大幅に増加し、15,628人から18,257人に増加したと報告しました。さらに、2019年には男性が9,134例であったのに対し、女性は6,494例であったが、2023年には男性10,639例、女性7,618例に増加しています。したがって、皮膚疾患の有病率の増加が外用薬CDMO市場の成長を牽引しています。

外用薬CDMO市場の主要企業は、市場での地位を維持するために最先端の製造施設の開発に注力しています。最先端の製造施設とは、外用医薬品の開発・製造に合わせた最新技術と高度なプロセスを備えた専門的な生産拠点のことです。例えば、米国の製薬会社SOHM Inc.は2023年11月、CDMO GMP製造施設を立ち上げました。カールスバッドの新施設は、外用医薬品の製造とSOHMの業務に十分なスペースを提供し、完成品の保管専用スペースは2,500平方フィートとなります。当初は、外用薬製造用に1日500ガロン（1,892リットル）の容量を持つ予定です。2024年第1四半期末または第2四半期初めまでには、ソフトジェル坐薬にも生産能力を拡大する予定です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界外用薬の開発・製造受託機関（CDMO） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の外用薬の開発・製造受託機関（CDMO）市場：成長率分析
• 世界の外用薬の開発・製造受託機関（CDMO）市場の実績：規模と成長, 2019-2024
• 世界の外用薬の開発・製造受託機関（CDMO）市場の予測：規模と成長, 2024-2029, 2034F
• 世界外用薬の開発・製造受託機関（CDMO）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の外用薬の開発・製造受託機関（CDMO）市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 半固形製剤
• 液体製剤医薬品
• 固形製剤
• 経皮吸収型製品
• 世界の外用薬の開発・製造受託機関（CDMO）市場：サービスタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 契約開発
• 契約製造
• 世界の外用薬の開発・製造受託機関（CDMO）市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚科
• 疼痛管理
• 創傷ケア
• 眼科
• その他の治療領域
• 世界の外用薬の開発・製造受託機関（CDMO）市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• バイオ医薬品企業
• その他の用途
• 世界の外用薬の開発・製造受託機関（CDMO）市場半固形製剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリーム
• 軟膏
• ゲル
• ペースト
• 世界の外用薬の開発・製造受託機関（CDMO）市場、液体製剤医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソリューション
• サスペンション
• エマルジョン
• ローション
• 世界の外用薬の開発・製造受託機関（CDMO）市場固形製剤の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉末
• タブレット
• 世界の外用薬の開発・製造受託機関（CDMO）市場経皮吸収型製品のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• パッチ

第7章 地域別・国別分析

• 世界の外用薬の開発・製造受託機関（CDMO）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の外用薬の開発・製造受託機関（CDMO）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 外用薬の開発・製造受託機関（CDMO）市場：競合情勢
• 外用薬の開発・製造受託機関（CDMO）市場：企業プロファイル
  • Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • The Lubrizol Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Catalent Inc.
• Bora Pharmaceuticals Co. Ltd.
• Recipharm AB
• Pierre Fabre S.A.
• Piramal Pharma Solutions
• Cambrex Corporation
• LTS Lohmann Therapie-Systeme AG
• PCI Pharma Services
• Famar S.A.
• Contract Pharmaceuticals Limited
• UPM Pharmaceuticals Inc.
• CoreRx Inc.
• Halo Pharmaceutical Inc.
• Tapemark Company
• Groupe PARIMA Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 外用薬の開発・製造受託機関（CDMO）市場2029：新たな機会を提供する国
• 外用薬の開発・製造受託機関（CDMO）市場2029：新たな機会を提供するセグメント
• 外用薬の開発・製造受託機関（CDMO）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that offers comprehensive services for developing, formulating, and producing topical pharmaceuticals. These services encompass research and development, clinical trial material production, and commercial manufacturing. CDMOs assist pharmaceutical companies in bringing topical drug products to market efficiently and in compliance with regulations.

The main product types offered by topical drug CDMOs include semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations consist of creams, ointments, gels, and pastes designed for topical application. Various service types provided include contract development and contract manufacturing for therapeutic areas such as dermatology, pain management, wound care, and ophthalmology, among others. The end-users of these services include pharmaceutical companies, biopharmaceutical companies, and others.

The topical drug contract development and manufacturing organization (CDMO) market research report is one of a series of new reports from The Business Research Company that provides topical drug contract development and manufacturing organization (CDMO) market statistics, including topical drug contract development and manufacturing organization (CDMO) industry global market size, regional shares, competitors with a topical drug contract development and manufacturing organization (CDMO) market share, detailed topical drug contract development and manufacturing organization (CDMO) market segments, market trends and opportunities, and any further data you may need to thrive in the topical drug contract development and manufacturing organization (CDMO) industry. This topical drug contract development and manufacturing organization (CDMO) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The topical drugs contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $52.9 billion in 2024 to $61.69 billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to chronic disease prevalence, advanced drug delivery technologies, cost-efficient outsourcing, regulatory demands, and growth in dermatology and cosmetics.

The topical drugs contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $113.06 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to personalized medicine, biologics expansion, increased R and D investments, rising skin disorder prevalence, and advanced manufacturing technologies. Major trends in the forecast period include increasing demand for innovative formulations, advancements in drug delivery technologies, rising investment in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and the growing consumer preference for over-the-counter (OTC) skincare products.

The increasing prevalence of skin diseases is expected to drive the growth of the topical drugs contract development and manufacturing organization (CDMO) market in the future. Skin diseases are medical conditions affecting the skin, causing symptoms such as inflammation, itching, and lesions. The rising prevalence of skin diseases can be attributed to factors such as environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. Topical drugs CDMOs help reduce skin disease prevalence by developing and manufacturing targeted therapies that improve the management and treatment of dermatological conditions. For example, in January 2024, Cancer Australia, an Australian-based cancer control agency, reported a significant increase in skin melanoma cases between 2019 and 2023, with numbers rising from 15,628 to 18,257. Additionally, in 2019, males had 9,134 cases compared to 6,494 females, while by 2023, the numbers had risen to 10,639 males and 7,618 females. Therefore, the increasing prevalence of skin diseases is driving the growth of the topical drugs CDMO market.

Major companies in the topical drugs CDMO market are focused on developing state-of-the-art manufacturing facilities to maintain their market position. A state-of-the-art manufacturing facility is a specialized production site equipped with the latest technology and advanced processes tailored for the development and manufacturing of topical pharmaceutical products. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, launched a CDMO GMP manufacturing facility. The new Carlsbad facility will offer ample space for manufacturing topical products and SOHM's operations, with 2,500 square feet dedicated to storing finished products. Initially, it will have a daily capacity of 500 gallons (1,892 liters) for manufacturing topicals. By the end of Q1 2024 or the start of Q2 2024, it is expected to expand its capacity to include soft-gel suppositories.

In April 2024, CoreRx Inc., a US-based pharmaceutical company, acquired Societal CDMO Inc. for $130 million. The acquisition is set to enhance CoreRx into a stronger CDMO, expanding its services from early-stage development to commercial manufacturing. It will streamline operations, increase market share, and provide long-term benefits such as improved economies of scale, better R&D, and a stronger competitive position. Societal CDMO Inc. is a US-based contract development and manufacturing organization that specializes in developing and manufacturing novel drug delivery formulations.

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd, Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The topical drugs contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as commercial manufacturing, research and development (R&D), regulatory support, and product lifecycle management. The market value includes the value of related goods sold by the service provider or included within the service offering. The topical drugs contract development and manufacturing organization (CDMO) market also includes sales of creams, ointments, gels, and lotions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on topical drugs contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for topical drugs contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The topical drugs contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Semi-Solid Formulations; Liquid Formulations Drugs; Solid Formulations; Transdermal Products
• 2) By Service Type: Contract Development; Contract Manufacturing
• 3) By Therapeutic Area: Dermatology; Pain Management; Wound Care; Ophthalmology; Other Therapeutic Areas
• 4) By End-Use: Pharmaceutical Companies; Biopharmaceutical Companies; Other End-Uses
• Subsegments:
• 1) By Semi-Solid Formulations: Creams; Ointments; Gels; Pastes
• 2) By Liquid Formulations Drugs: Solutions; Suspensions; Emulsions; Lotions
• 3) By Solid Formulations: Powders; Tablets
• 4) By Transdermal Products: Patches
• Companies Mentioned: Evonik Industries AG; Eurofins Scientific SE; SGS SA; The Lubrizol Corporation; Lonza Group AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

• 5.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis
• 5.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

• 6.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Semi-Solid Formulations
• Liquid Formulations Drugs
• Solid Formulations
• Transdermal Products
• 6.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Development
• Contract Manufacturing
• 6.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatology
• Pain Management
• Wound Care
• Ophthalmology
• Other Therapeutic Areas
• 6.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Other End-Uses
• 6.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Creams
• Ointments
• Gels
• Pastes
• 6.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solutions
• Suspensions
• Emulsions
• Lotions
• 6.7. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powders
• Tablets
• 6.8. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patches

7. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

• 7.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 8.1. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 9.1. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 9.2. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 10.1. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 11.1. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 11.2. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 12.1. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 13.1. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 14.1. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 14.2. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 15.1. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 15.2. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 16.1. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 17.1. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 18.1. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 19.1. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 20.1. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 21.1. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 21.2. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 22.1. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 23.1. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 23.2. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 24.1. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 24.2. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 25.1. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 25.2. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 26.1. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 26.2. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 27.1. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 28.1. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 28.2. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

• 29.1. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview
• 29.2. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

• 30.1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape
• 30.2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
  • 30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. SGS SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. The Lubrizol Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

• 31.1. Catalent Inc.
• 31.2. Bora Pharmaceuticals Co. Ltd.
• 31.3. Recipharm AB
• 31.4. Pierre Fabre S.A.
• 31.5. Piramal Pharma Solutions
• 31.6. Cambrex Corporation
• 31.7. LTS Lohmann Therapie-Systeme AG
• 31.8. PCI Pharma Services
• 31.9. Famar S.A.
• 31.10. Contract Pharmaceuticals Limited
• 31.11. UPM Pharmaceuticals Inc.
• 31.12. CoreRx Inc.
• 31.13. Halo Pharmaceutical Inc.
• 31.14. Tapemark Company
• 31.15. Groupe PARIMA Inc.

32. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

35. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

• 35.1 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer